Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

FuRong Wang

Showing results (231-240 of 234) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 234 results.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Epilepsy & Behavior : E&B|August 25, 2023
COVID-19 vaccination for patients with epilepsy: A Chinese expert consensusXuewu Liu, Qun Wang, Liankun Ren, et al.
The New England Journal of Medicine|November 25, 2010
Preexposure chemoprophylaxis for HIV prevention in men who have sex with menRobert M Grant, Javier R Lama, Peter L Anderson, et al.
Pageof 24

Showing results (231-240 of 234) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 234 results.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Epilepsy & Behavior : E&B|August 25, 2023
COVID-19 vaccination for patients with epilepsy: A Chinese expert consensusXuewu Liu, Qun Wang, Liankun Ren, et al.
The New England Journal of Medicine|November 25, 2010
Preexposure chemoprophylaxis for HIV prevention in men who have sex with menRobert M Grant, Javier R Lama, Peter L Anderson, et al.
Pageof 24